Published on 17 Oct 2023 on Simply Wall St. via Yahoo Finance
Insiders who bought US$1.81m worth of Vicarious Surgical Inc.'s (NYSE:RBOT) stock at an average buy price of US$2.47 over the last year may be disappointed by the recent 14% decrease in the stock. Insiders buy with the expectation to see their investments rise in value over a period of time. However, recent losses have rendered their above investment worth US$317.9k which is not ideal.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Vicarious Surgical